Similar articles for PMID: 21330392

Year	Number of Results
1978	1
1979	1
1982	1
1988	2
1991	2
1994	1
1995	1
1996	1
1997	1
1998	1
1999	1
2000	1
2003	2
2004	3
2005	1
2006	2
2007	3
2008	3
2009	4
2010	7
2011	7
2012	5
2013	6
2014	2
2015	5
2016	8
2017	15
2018	13
2019	11
2020	2
2021	2
2022	1
2024	0

1

Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors?

Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S, Rock JP, Rosenblum M, Gutierrez J, Mikkelsen T. Jain R, et al. AJNR Am J Neuroradiol. 2011 Apr;32(4):658-63. doi: 10.3174/ajnr.A2378. Epub 2011 Feb 17. AJNR Am J Neuroradiol. 2011. PMID: 21330392 Free PMC article.

2

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.

Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearshen D, Babajani-Feremi A. Narang J, et al. Neuro Oncol. 2011 Sep;13(9):1037-46. doi: 10.1093/neuonc/nor075. Epub 2011 Jul 29. Neuro Oncol. 2011. PMID: 21803763 Free PMC article.

3

Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.

Hojjati M, Badve C, Garg V, Tatsuoka C, Rogers L, Sloan A, Faulhaber P, Ros PR, Wolansky LJ. Hojjati M, et al. J Neuroimaging. 2018 Jan;28(1):118-125. doi: 10.1111/jon.12460. Epub 2017 Jul 18. J Neuroimaging. 2018. PMID: 28718993 Free PMC article.

4

First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis.

Jain R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY, Mikkelsen T. Jain R, et al. Neurosurgery. 2007 Oct;61(4):778-86; discussion 786-7. doi: 10.1227/01.NEU.0000298906.48388.26. Neurosurgery. 2007. PMID: 17986939

5

Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?

Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A, Caporale N, Pace A, Crecco M, Marzi S. Vidiri A, et al. Eur J Radiol. 2012 Jun;81(6):1246-52. doi: 10.1016/j.ejrad.2011.02.068. Epub 2011 Mar 31. Eur J Radiol. 2012. PMID: 21458183

6

Differentiation of Recurrent Glioblastoma from Delayed Radiation Necrosis by Using Voxel-based Multiparametric Analysis of MR Imaging Data.

Yoon RG, Kim HS, Koh MJ, Shim WH, Jung SC, Kim SJ, Kim JH. Yoon RG, et al. Radiology. 2017 Oct;285(1):206-213. doi: 10.1148/radiol.2017161588. Epub 2017 May 23. Radiology. 2017. PMID: 28535120

7

Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.

Masch WR, Wang PI, Chenevert TL, Junck L, Tsien C, Heth JA, Sundgren PC. Masch WR, et al. Acad Radiol. 2016 May;23(5):569-76. doi: 10.1016/j.acra.2015.11.015. Epub 2016 Feb 23. Acad Radiol. 2016. PMID: 26916251 Free PMC article.

8

Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors.

Shah AH, Kuchakulla M, Ibrahim GM, Dadheech E, Komotar RJ, Gultekin SH, Ivan ME. Shah AH, et al. World Neurosurg. 2019 Jan;121:e836-e842. doi: 10.1016/j.wneu.2018.09.233. Epub 2018 Oct 9. World Neurosurg. 2019. PMID: 30312826

9

Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.

Muto M, Frauenfelder G, Senese R, Zeccolini F, Schena E, Giurazza F, Jäger HR. Muto M, et al. Radiol Med. 2018 Jul;123(7):545-552. doi: 10.1007/s11547-018-0866-7. Epub 2018 Mar 5. Radiol Med. 2018. PMID: 29508242

10

Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.

Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, Rosenblum M, Patel SC, Mikkelsen T. Narang J, et al. J Neurooncol. 2011 Apr;102(2):287-93. doi: 10.1007/s11060-010-0317-3. Epub 2010 Aug 1. J Neurooncol. 2011. PMID: 20680399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year